dr. biao he

A University of Georgia Researcher is approaching a breakthrough in his efforts to develop a second-generation COVID-19 vaccine. Dr. Biao He was able to get his vaccine produced and testing done earlier this year, but the pandemic forced some measures to be postponed.

“So our community trial got postponed, and I’m glad to tell you right now, we got cleared by [the] FDA for community trial and we are hoping on July 26th, we will have the first patient in for the testing in the U.S.,” according to He.

This week on Athens News Matters:

Athens News Matters: Dr. Biao He

Dec 11, 2020

Dr. Biao He, a professor at the Department of Infectious Diseases at UGA's College of Veterinary Medicine, has developed a vaccine for COVID-19 which is ready for human clinical trials. Contrary to other vaccines , this will be a single-dose, nasal spray.

UGA Today

The effort to get a COVID-19 vaccine developed by a UGA researcher is nearing completion. While the vaccine was shipped in early October, a manufacturing delay means the start of human trials is scheduled for early next year.

Dr. Biao He is a professor of infectious diseases at UGA’s Vet School. He has worked on vaccine development for some 20 years.

The urgency to create a COVID-19 vaccine is increasing, and scientists are working around the clock to accomplish this daunting task. Dr. Biao He, an infectious disease expert at the University of Georgia, is one of those scientists, and his vaccine is already showing promising results. 

Pages